Skip to main content
NIH funding notice RFA-NS-19-030

Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed)

Closed on April 15, 2019.

Posted
February 25, 2019
Close date
April 15, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,076,234 in first-year total cost, median $2,038,117.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BDCN-Y (55)]2

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
  2. UNIVERSITY OF PENNSYLVANIA1
Competing awards under RFA-NS-19-030 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes1U54NS115266-01MCKEE, ANN C.BOSTON UNIVERSITY MEDICAL CAMPUS, MA$2,086,962ZRG1
2019CONNECT-TBI1U54NS115322-01SMITH, DOUGLAS HAMILTONSTEWART, WILLIAMUNIVERSITY OF PENNSYLVANIA, PA$1,989,272ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-NS-19-030: Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed) | ScienceDex | ConductScience